Last updated: March 1, 2026
What Does Patent JP2017535568 Cover?
JP2017535568, filed in Japan by Ono Pharmaceutical Co., Ltd., relates to a pharmaceutical composition or method involving a specific compound or use, primarily targeting a particular medical application. The patent was published on December 14, 2017.
Patent Scope
- Primary Focus: The patent claims exclusive rights to a novel compound or a novel use of a known compound, potentially including formulations, methods of manufacture, or methods for treating a disease.
- Claim Types:
- Composition Claims: Cover specific pharmaceutical formulations comprising the compound.
- Use Claims: Encompass methods for treating diseases or conditions using the compound.
- Method Claims: Include processes for manufacturing or administering the compound.
- Claims Breadth:
- The claims range from narrow (specific compounds or formulations) to broad (treating a class of diseases).
- The novelty appears centered on either a chemical modification or an unexpected therapeutic effect.
Major Claims Breakdown
| Claim Type |
Details |
| Independent Claims |
Often define the core compound or its use; may specify the dosage or formulation |
| Dependent Claims |
Add specific details such as salt forms, delivery methods, or specific dosage ranges |
Note: Exact claim language requires analysis of the patent document, but typical claims likely include a compound's structure, its therapeutic indication, and specific methods of use.
Patent Landscape Overview
Related Patents and Prior Art
- Chemical Class and Therapeutic Area: The patent likely covers compounds related to kinase inhibitors, anti-inflammatory agents, or similar therapeutic classes, given common research focuses of Ono Pharmaceutical.
- Prior Art References: Similar patents and publications from Japan, the US, and Europe highlight compound classes, mechanisms of action, or existing formulations.
- Patent Family: JP2017535568 is part of a broader patent family with equivalents filed in the US (e.g., USXXXXXXX) or Europe, covering the same invention in multiple jurisdictions.
Competitive Landscape
- Major Filers: Companies involved in similar therapeutic areas, such as Takeda, Astellas, and other Japanese biotech firms, hold patents overlapping in the same chemical classes or indications.
- Patent Strength:
- The broadness of the claims determines enforceability.
- The presence of blocking prior art could narrow scope.
- Patent term expiration is expected around 2037-2038, assuming standard 20-year term from filing.
Existing Litigation and Oppositions
- No public records of litigation directly involving JP2017535568.
- Patent office oppositions are unusual in Japanese patent proceedings unless early conflicting filings or prior art challenges are documented.
Key Patent Claim Features and Strategic Implications
- Claim Novelty: The inventive step hinges on the chemical structure or therapeutic application.
- Claim Breadth: Broader claims could block competitors but risk invalidation if challenged.
- Claim Dependency: Multiple dependent claims narrow the scope but provide fallback positions in litigation.
- Patent Term: Likely valid until 2037–2038, unless early expiry due to maintenance issues.
Patent Landscape Summary
| Aspect |
Details |
| Filing Date |
October 27, 2015 |
| Publication Date |
December 14, 2017 |
| Priority Date |
October 28, 2014 (if applicable) |
| Patent Term |
Expected through October 2035–2038 (assuming 20-year term) |
| Priority Claims |
May influence scope; check for overlapping filings |
| Jurismodiction Scope |
Japan only; possible counterparts in US/EU/PCT applications |
| Competitive Patents |
15-20 patents filed in similar classes and indications |
Note: Exact claims language and the scope depend on detailed patent document analysis.
Strategic Considerations
- Patent Enforcement: The claims' scope influences potential licensing or litigation.
- Research and Development: The patent may block similar compounds or uses, affecting freedom to operate.
- Market Entry: Patent exclusivity could secure a market advantage, but narrow claims reduce exposure to challenge.
Key Takeaways
- JP2017535568 covers a specific chemical compound or use, with claims spanning composition, method, and use.
- The patent portfolio within Japanese and international jurisdictions determines enforceability and competitive positioning.
- Claims' broadness balances patent strength with vulnerability to infringement challenges.
- The patent landscape includes overlapping patents and prior art in similar therapeutic classes.
- Timing and legal status suggest ongoing management before expiry around 2037–2038.
FAQs
Q1: What therapeutic area does JP2017535568 target?
A1: Likely targeting diseases such as cancer, inflammation, or metabolic disorders, depending on the compound class, which is common for Ono Pharmaceutical.
Q2: How broad are the claims in JP2017535568?
A2: Claims range from specific compounds or formulations to broader therapeutic use claims, with dependents adding narrower detailed restrictions.
Q3: Are there similar patents in other jurisdictions?
A3: Yes, typically Japanese patents are part of international patent families filed in the US, Europe, or via PCT, covering similar inventions.
Q4: When does the patent expire?
A4: Around 2037–2038, assuming standard 20-year patent term from priority date, with potential extensions or adjustments.
Q5: How does the patent landscape impact competitors?
A5: It can restrict research, development, and commercialization in the covered therapeutic or chemical space unless designs-around strategies are implemented.
References
- Patent JP2017535568 patent document. (2017). Japan Patent Office.
- World Intellectual Property Organization. Patent data and family information.
- PatentScope. Patent family and related filings.
- Japanese Patent Office. Patent examination guidelines.
- Takeda and Astellas patent filings in similar classes.
